PATENT CLAIM ANALYSIS

Application Number: 15903725
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["436", "501000"]

Abstract:
Devices, solutions and method capable of quantifying a clinically significant amount of antibodies within a plasma sample obtained from an individual by quantifying binding between antibodies within the sample and microbial proteins are disclosed.

Claim (Index 4):
The method of  claim 1 , further comprising:\n exposing the first microbial protein to a labeled antibody against the first microbial protein, wherein the labeled antibody against the first microbial protein comprises a first fluorophore; and exposing the first microbial protein exposed to the plasma sample to a labeled antibody against antibodies, the labeled antibody against antibodies comprising a second fluorophore capable of participating in an energy transfer with the first fluorophore the labeled antibody against the first microbial protein and the labeled antibody against antibodies are collectively bound to the first microbial protein, and wherein quantifying binding comprises quantifying energy transfer between first and second fluorophore.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.24138
- Patent Class: 436.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12047131', '13732434', '13060399', '13459192', '11786193']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6744667353925609
- 35 USC 102 Novelty (BERT): 0.4696241434770237
- Combined Prediction Score: 0.6539824762010071
- Mean Citation Score: 210.28351400000005
- Max Citation Score: 217.84291
- Similarity Product: 171.10343719464896

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test